Christian Kanstrup
Chief Executive Officer bij EVAXION BIOTECH A/S
Vermogen: 47 090 $ op 31-03-2024
Profiel
Christian Kanstrup is currently the Chief Executive Officer at Evaxion Biotech A, Director at NNIT A, and Chairman at Mediq Holding Danmark ApS.
He is also a Director at Novo Nordisk Haemophilia Foundation.
In the past, he worked as a Director at FastPassCorp A, Director at Glycom A, and SVP-Strategy, Access & Marketing at Novo Nordisk A.
He has a graduate degree from the University of Copenhagen and a graduate degree from the International Institute for Management Development.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
NNIT A/S
0.01% | 31-12-2023 | 3 000 ( 0.01% ) | 47 090 $ | 31-03-2024 |
Actieve functies van Christian Kanstrup
| Bedrijven | Functie | Begin |
|---|---|---|
| NNIT A/S | Director/Board Member | 08-03-2018 |
| EVAXION BIOTECH A/S | Chief Executive Officer | 29-08-2023 |
| Novo Nordisk Haemophilia Foundation | Director/Board Member | - |
Mediq Holding Danmark ApS
 Mediq Holding Danmark ApS Financial ConglomeratesFinance Part of Mediq BV, Mediq Holding Danmark ApS is a Danish company that functions as an investment holding company. The private company is based in Brøndby, Denmark. The company was founded in 2010 by Jesper Schultz Larsen. The CEO is Katrine Bjarkov Benthien. | Chairman | - |
Eerdere bekende functies van Christian Kanstrup
| Bedrijven | Functie | Einde |
|---|---|---|
| FASTPASSCORP A/S | Director/Board Member | 02-03-2019 |
Glycom A/S
 Glycom A/S BiotechnologyHealth Technology Glycom A/S engages in the development, synthesis, and commercialization of human milk oligosaccharides. It develops chemical and enzymatic technologies for synthesis of human milk oligosaccharide powders. The company was founded by Gyuala Dekany, Mark von Itzstein, Joachim Erich Thiem, Arnold Stutz, and Inge Lundt on March 22, 2005 and is headquartered in Horsholm, Denmark. | Director/Board Member | - |
| NOVO NORDISK A/S | Corporate Officer/Principal | - |
Opleiding van Christian Kanstrup
| University of Copenhagen | Graduate Degree |
| International Institute for Management Development | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| FASTPASSCORP A/S | Technology Services |
| NNIT A/S | Technology Services |
| EVAXION BIOTECH A/S | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Glycom A/S
Glycom A/S BiotechnologyHealth Technology Glycom A/S engages in the development, synthesis, and commercialization of human milk oligosaccharides. It develops chemical and enzymatic technologies for synthesis of human milk oligosaccharide powders. The company was founded by Gyuala Dekany, Mark von Itzstein, Joachim Erich Thiem, Arnold Stutz, and Inge Lundt on March 22, 2005 and is headquartered in Horsholm, Denmark. | Health Technology |
| Novo Nordisk Haemophilia Foundation | |
Mediq Holding Danmark ApS
Mediq Holding Danmark ApS Financial ConglomeratesFinance Part of Mediq BV, Mediq Holding Danmark ApS is a Danish company that functions as an investment holding company. The private company is based in Brøndby, Denmark. The company was founded in 2010 by Jesper Schultz Larsen. The CEO is Katrine Bjarkov Benthien. | Finance |
